4//SEC Filing
Danilkovitch Alla 4
Accession 0001123292-17-001446
CIK 0001360886other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 5:14 PM ET
Size
7.5 KB
Accession
0001123292-17-001446
Insider Transaction Report
Form 4
Danilkovitch Alla
Chief Scientific Officer
Transactions
- Award
Non-qualified Stock Option (right to buy)
2017-07-19$6.80/sh+15,466$105,169→ 139,000 totalExercise: $6.80From: 2018-07-19Exp: 2027-07-19→ Common Stock (15,466 underlying) - Award
Incentive Stock Option (right to buy)
2017-07-19$6.80/sh+34,534$234,831→ 125,534 totalExercise: $6.80From: 2018-07-19Exp: 2027-07-19→ Common Stock (34,534 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest on each of July 19, 2018, July 19, 2019, July 19, 2020 and July 19, 2021, subject to Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
OSIRIS THERAPEUTICS, INC.
CIK 0001360886
Entity typeother
Related Parties
1- filerCIK 0001636236
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 5:14 PM ET
- Size
- 7.5 KB